Publications

2019

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, et al. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood. 2019;133(15):1664-1676.
Hamid AA, Gray KP, Huang Y, Bowden M, Pomerantz M, Loda M, et al. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy. Eur Urol Oncol. 2019;2(5):475-482.
Vlachostergios PJ, Geyer JT, Miller J, Kosloff R, Beltran H, Tagawa ST. Exceptional Response to Pembrolizumab in a Patient With Castration-Resistant Prostate Cancer With Pancytopenia From Myelophthisis. J Oncol Pract. 2019;15(6):343-345.
Geyer JT. Myeloid Neoplasms with Germline Predisposition. Pathobiology. 2019;86(1):53-61.
Cimic A, Wilkin TJ, Heymann JJ, Alperstein S, Ellsworth G, Siddiqui MT. Importance of anal cytology and screening for anal dysplasia in individuals living with HIV with an emphasis on women. Cancer Cytopathol. 2019;127(6):407-413.
Ji G, Xu R, Niu Y, Li N, Ivashkiv L, Bostrom MP, et al. Vascular endothelial growth factor pathway promotes osseointegration and CD31EMCN endothelium expansion in a mouse tibial implant model: an animal study. Bone Joint J. 2019;101-B(7_Supple_C):108-114.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, et al. MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma. J Neuroimaging. 2019;29(3):357-363.
Solomon JP, Benayed R, Hechtman JF, Ladanyi M. Identifying patients with NTRK fusion cancer. Ann Oncol. 2019;30 Suppl 8:viii16-viii22.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700